Yet some discrepancies exist [187], and ongoing research is expected to shed light about the potential benefit of PD-1/PD-L1 blockade for the treatment of the DLBCL histologic variant of RS. The gene discussed is CD274; the disease is diffuse large B-cell lymphoma.